Jane Street
AARD icon

Jane Street’s Aardvark Therapeutics AARD Stock Holding History

Jane Street’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$362K Buy
68,636
+46,172
+206% +$282K ﹤0.01% 8759
2026
Q2 		$129K Buy
+22,464
New +$105K ﹤0.01% 10452
2025
Q4 		– Sell
-19,447
Closed -$258K – 12801
2025
Q3 		$258K Buy
+19,447
New +$219K ﹤0.01% 9204

Other funds holding AARD

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Smith, Moore & Co
Smith, Moore & Co Clayton, Missouri $1.55B AUM 16.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

Jane Street's AARD Position: Q3 2026 in Review

Jane Street increased its Aardvark Therapeutics (AARD) stake by 206% in Q3 2026, buying an estimated $282K and bringing the position to 68,636 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #8759.

Jane Street first reported a position in AARD in Q3 2025 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

  • Jane Street held 68,636 shares of Aardvark Therapeutics worth $362K as of Q3 2026.
  • Jane Street bought 46,172 Aardvark Therapeutics shares in Q3 2026, an estimated $282K.
  • Aardvark Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8759 holding.
  • Jane Street first reported a position in Aardvark Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.